Big Pharma Mergers and Acquisitions: Clinical Trials Visualizer

Interactive visualizer showing how major pharmaceutical mergers and acquisitions relate to clinical trial activity, R&D spending, and market trends over time.

Big Pharma Mergers and Acquisitions: Clinical Trials Visualizer

Interactive visualizer showing how major pharmaceutical mergers and acquisitions relate to clinical trial activity, R&D spending, and market trends over time.
Cyntegrity logo – Risk-Based Quality Management Solutions

Why This Visualizer Exists

This visualizer brings together clinical trial, financial, and market data to help users examine how large-scale mergers and acquisitions have shaped the pharmaceutical landscape.

 

By placing major M&A events alongside changes in trial volume, R&D spending, and share price performance, it supports a clearer interpretation of how strategic corporate decisions can influence clinical research activity over time.

What You Can Explore With the Visualizer

Key ways the visualizer supports analysis and learning

Explore M&A timelines in context

Review major pharmaceutical mergers and acquisitions since 2000 and see how they align with changes in clinical trial activity and corporate performance.

Compare clinical trial activity before and after deals

Observe how the number of registered trials evolves around M&A events, supporting reflection on potential consolidation or expansion effects.

Connect R&D investment and market signals

View R&D spending and share price trends alongside clinical data to better understand the broader strategic environment in which trials are conducted.

About the Visual Approach

The visualizer integrates publicly available data from ClinicalTrials.gov, SEC filings, and historical market data sources, covering the period from 2000 to 2022. The visual design emphasizes temporal alignment, allowing users to interpret how clinical, financial, and market indicators move in relation to M&A events rather than drawing causal conclusions.

How do large mergers appear when clinical and financial data are viewed together?

Explore the visual relationships and form your own interpretations based on transparent, referenced data sources.

Part of the eyesON Interactive Visualizer Series

The eyesON series is Cyntegrity’s collection of interactive data visualizers created to support understanding through transparent, well-structured data exploration. These tools are developed as learning resources, making complex datasets more accessible without oversimplifying them.

 

Through the eyesON series, Cyntegrity shares its data analytics expertise and regulatory knowledge with the broader research community. Each visualizer transforms dense guidance and datasets into meaningful visual narratives that support learning, cross-functional dialogue, and practical understanding. Explore More Interactive Visualizers…

Explore Our Visualizer

Interactive visualizer showing how major pharmaceutical mergers and acquisitions relate to clinical trial activity, R&D spending, and market trends over time.

Stay Informed with Us

Risk-based quality management in 2026

Risk-based quality management in 2026: how ICH E6(R3) defines RBQM, where practice diverges, and what regulators now expect in clinical trials....
Diagram illustrating the FDA Total Product Lifecycle (TPLC) management approach for AI and machine learning devices, showing a continuous cycle of design, validation, submission, monitoring, and update.

FDA AI Guidance 2025 Interactive Visualizer

Explore how FDA’s 2025 AI guidance shapes lifecycle oversight for AI-enabled medical software through interactive regulatory scenarios....

Media Inquiries

Need a quote, speaker, or more info about Cyntegrity? Reach out directly to our media contact for timely assistance.